TrialClinical cancer research : an official journal of the American Association for Cancer Research2008

Phase II trial of tipifarnib as maintenance therapy in first complete remission in adults with acute myelogenous leukemia and poor-risk features.

Judith E Karp et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.